Phase
Condition
Gastric Cancer
Stomach Cancer
Digestive System Neoplasms
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients aged 18 to 75 years;
Ultrasound gastroscopy or imaging (CT) can diagnose potentially unresectable gastriccancer (T4a-bN2-3M0) with indications of neoadjuvant chemotherapy or transformationtherapy;
Pathological diagnosis of gastric cancer;
No contraindication of chemotherapy;
Patients who did not undergo chemotherapy or were diagnosed for the first time.
Exclusion
Exclusion Criteria:
Those who fail to comply with the requirements of the trial, obviously violate thisregimen, or change to other regimens in the course of treatment;
The life expectancy of patients with extensive systemic metastasis is less than 3months;
Leukocyte count is less than 2109/L and platelet count is less than 7510^9/L;
Severe heart, liver and kidney diseases, unable to tolerate chemotherapy;
Patients without gastric cancer complications such as massive gastrointestinalbleeding and perforation need to be treated in emergency department;
Patients with distant metastasis (excluding group 16 lymph node metastasis);
Patients with other tumors, with a history of malignant tumors (excluding earlyprimary cancers);
The patient himself asked to withdraw from the trial;
Researchers believe that patients are not suitable for this study.
Study Design
Connect with a study center
The Second affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang 310000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.